ArticleHuman vaccines & immunotherapeutics2022

Safety of the 15-valent pneumococcal conjugate vaccine: A phase I clinical trial.

Lu-Lu Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.